Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation

Read original: arXiv:2407.13779 - Published 7/22/2024 by Siddartha Reddy N, Sai Prakash MV, Varun V, Vishal Vaddina, Saisubramaniam Gopalakrishnan
Total Score

0

Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Targeted molecule generation is a key challenge in drug discovery and materials design
  • This paper introduces a novel method called Latent Evolutionary Optimization (LEO) to generate molecules with desired properties
  • LEO combines a variational autoencoder (VAE) with an evolutionary algorithm to efficiently search the latent space of molecules

Plain English Explanation

Developing new molecules with specific properties, like being effective drugs or having desirable material characteristics, is a major challenge in science and engineering. This paper presents a technique called Latent Evolutionary Optimization (LEO) that aims to make this process more efficient.

LEO works by first training a variational autoencoder (VAE) on a large dataset of molecules. The VAE learns to encode molecules into a compact "latent space" representation, which captures the essential features of each molecule in a concise way.

Then, LEO uses an evolutionary algorithm to search through this latent space, looking for molecules that have the desired properties. The evolutionary algorithm gradually "evolves" the latent representations, making small changes and keeping the ones that seem to be getting closer to the target.

By searching the efficient latent space instead of the full space of all possible molecules, LEO is able to generate targeted molecules much more quickly and effectively than previous methods. This could be very useful for applications like drug discovery, where finding the right molecular structure is crucial.

Technical Explanation

The key innovation in this paper is the combination of a variational autoencoder (VAE) and an evolutionary algorithm to perform targeted molecule generation.

The VAE is first trained on a large dataset of molecules, learning to encode each molecule into a compact latent space representation. This latent space captures the essential features of the molecules in a concise way, allowing for efficient searching and manipulation.

The evolutionary algorithm is then used to navigate this latent space, making small changes to the latent representations and evaluating the resulting molecules against the desired target properties. The "fittest" latent representations are selected and used to generate the next generation of candidate molecules. This evolutionary process gradually converges on molecules that match the target criteria.

By integrating the VAE's latent space with the evolutionary algorithm's optimization capabilities, LEO is able to efficiently explore the space of possible molecules and generate targeted structures. The authors demonstrate the effectiveness of this approach on several benchmark molecule generation tasks, showing that LEO outperforms previous state-of-the-art methods.

Critical Analysis

The authors acknowledge several limitations of the LEO approach. First, the performance of the method is dependent on the quality of the initial VAE model, which needs to be trained on a large and representative dataset of molecules. If the dataset is biased or incomplete, the latent space may not capture all the relevant molecular features.

Additionally, the evolutionary algorithm used in LEO relies on heuristics and can be sensitive to hyperparameter choices. The authors note that further research is needed to better understand the interplay between the VAE and the evolutionary optimization, and to potentially develop more robust search strategies.

Another potential issue is the interpretability of the latent space representations. While the compact latent encoding is useful for efficient optimization, it may be difficult to fully explain the reasoning behind the generated molecules. This could be a concern for applications where transparency and understanding the "why" behind the molecule generation is important, such as in drug discovery.

Despite these caveats, the LEO framework represents a promising approach to targeted molecule generation that combines the strengths of deep generative models and evolutionary optimization. Further research in this area could lead to significant advancements in materials design, chemical synthesis, and other fields where the ability to efficiently generate molecules with desired properties is crucial.

Conclusion

This paper introduces Latent Evolutionary Optimization (LEO), a novel method for targeted molecule generation that leverages the representation learning capabilities of variational autoencoders and the optimization power of evolutionary algorithms. By searching the efficient latent space of molecules, LEO is able to generate candidate structures that match desired properties much more effectively than previous approaches.

The integration of deep generative models and evolutionary techniques represents an exciting direction for molecular design, with potential applications in drug discovery, materials science, and beyond. While the LEO method has some limitations that require further research, it demonstrates the value of combining cutting-edge AI and optimization techniques to tackle complex scientific challenges.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation
Total Score

0

Leveraging Latent Evolutionary Optimization for Targeted Molecule Generation

Siddartha Reddy N, Sai Prakash MV, Varun V, Vishal Vaddina, Saisubramaniam Gopalakrishnan

Lead optimization is a pivotal task in the drug design phase within the drug discovery lifecycle. The primary objective is to refine the lead compound to meet specific molecular properties for progression to the subsequent phase of development. In this work, we present an innovative approach, Latent Evolutionary Optimization for Molecule Generation (LEOMol), a generative modeling framework for the efficient generation of optimized molecules. LEOMol leverages Evolutionary Algorithms, such as Genetic Algorithm and Differential Evolution, to search the latent space of a Variational AutoEncoder (VAE). This search facilitates the identification of the target molecule distribution within the latent space. Our approach consistently demonstrates superior performance compared to previous state-of-the-art models across a range of constrained molecule generation tasks, outperforming existing models in all four sub-tasks related to property targeting. Additionally, we suggest the importance of including toxicity in the evaluation of generative models. Furthermore, an ablation study underscores the improvements that our approach provides over gradient-based latent space optimization methods. This underscores the effectiveness and superiority of LEOMol in addressing the inherent challenges in constrained molecule generation while emphasizing its potential to propel advancements in drug discovery.

Read more

7/22/2024

🛠️

Total Score

0

Multi-Objective Latent Space Optimization of Generative Molecular Design Models

A N M Nafiz Abeer, Nathan Urban, M Ryan Weil, Francis J. Alexander, Byung-Jun Yoon

Molecular design based on generative models, such as variational autoencoders (VAEs), has become increasingly popular in recent years due to its efficiency for exploring high-dimensional molecular space to identify molecules with desired properties. While the efficacy of the initial model strongly depends on the training data, the sampling efficiency of the model for suggesting novel molecules with enhanced properties can be further enhanced via latent space optimization. In this paper, we propose a multi-objective latent space optimization (LSO) method that can significantly enhance the performance of generative molecular design (GMD). The proposed method adopts an iterative weighted retraining approach, where the respective weights of the molecules in the training data are determined by their Pareto efficiency. We demonstrate that our multi-objective GMD LSO method can significantly improve the performance of GMD for jointly optimizing multiple molecular properties.

Read more

7/23/2024

🤿

Total Score

0

Deep Lead Optimization: Leveraging Generative AI for Structural Modification

Odin Zhang, Haitao Lin, Hui Zhang, Huifeng Zhao, Yufei Huang, Yuansheng Huang, Dejun Jiang, Chang-yu Hsieh, Peichen Pan, Tingjun Hou

The idea of using deep-learning-based molecular generation to accelerate discovery of drug candidates has attracted extraordinary attention, and many deep generative models have been developed for automated drug design, termed molecular generation. In general, molecular generation encompasses two main strategies: de novo design, which generates novel molecular structures from scratch, and lead optimization, which refines existing molecules into drug candidates. Among them, lead optimization plays an important role in real-world drug design. For example, it can enable the development of me-better drugs that are chemically distinct yet more effective than the original drugs. It can also facilitate fragment-based drug design, transforming virtual-screened small ligands with low affinity into first-in-class medicines. Despite its importance, automated lead optimization remains underexplored compared to the well-established de novo generative models, due to its reliance on complex biological and chemical knowledge. To bridge this gap, we conduct a systematic review of traditional computational methods for lead optimization, organizing these strategies into four principal sub-tasks with defined inputs and outputs. This review delves into the basic concepts, goals, conventional CADD techniques, and recent advancements in AIDD. Additionally, we introduce a unified perspective based on constrained subgraph generation to harmonize the methodologies of de novo design and lead optimization. Through this lens, de novo design can incorporate strategies from lead optimization to address the challenge of generating hard-to-synthesize molecules; inversely, lead optimization can benefit from the innovations in de novo design by approaching it as a task of generating molecules conditioned on certain substructures.

Read more

5/1/2024

🛠️

Total Score

0

Human-level molecular optimization driven by mol-gene evolution

Jiebin Fang (Hainan Institute of Zhejiang University, Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University), Churu Mao (Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University), Yuchen Zhu (College of Pharmaceutical Sciences and Cancer Center, Zhejiang University), Xiaoming Chen (Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University), Chang-Yu Hsieh (College of Pharmaceutical Sciences and Cancer Center, Zhejiang University), Zhongjun Ma (Hainan Institute of Zhejiang University, Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University)

De novo molecule generation allows the search for more drug-like hits across a vast chemical space. However, lead optimization is still required, and the process of optimizing molecular structures faces the challenge of balancing structural novelty with pharmacological properties. This study introduces the Deep Genetic Molecular Modification Algorithm (DGMM), which brings structure modification to the level of medicinal chemists. A discrete variational autoencoder (D-VAE) is used in DGMM to encode molecules as quantization code, mol-gene, which incorporates deep learning into genetic algorithms for flexible structural optimization. The mol-gene allows for the discovery of pharmacologically similar but structurally distinct compounds, and reveals the trade-offs of structural optimization in drug discovery. We demonstrate the effectiveness of the DGMM in several applications.

Read more

6/21/2024